Validation of c-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: British Journal of Cancer, 110, 1, S. 183-188

Event: Veröffentlichung

(where): Augsburg

(who): Universität Augsburg

(when): 2013

Event: Veröffentlichung

(who): Springer Science and Business Media LLC

(when): 2013

Creator: Szkandera, J.
Stotz, M.
Absenger, G.
Stojakovic, T.
Samonigg, H.
Kornprat, P.
Schaberl-Moser, R.
AlZoughbi, W.
Lackner, C.
Ress, A. L.
Seggewies, F. S.
Gerger, A.
Hoefler, G.
Pichler, Martin

DOI: 10.1038/bjc.2013.701

URN: urn:nbn:de:bvb:384-opus4-1036439

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:00 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Szkandera, J.
Stotz, M.
Absenger, G.
Stojakovic, T.
Samonigg, H.
Kornprat, P.
Schaberl-Moser, R.
AlZoughbi, W.
Lackner, C.
Ress, A. L.
Seggewies, F. S.
Gerger, A.
Hoefler, G.
Pichler, Martin
Universität Augsburg
Springer Science and Business Media LLC

Time of origin

2013

Other Objects (12)

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Validation of c-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

C-reactive protein and neutrophil/lymphocytes ratio: prognostic indicator for doubling overall survival prediction in pancreatic cancer patients

So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt

Best of ASCO 2022: bladder cancer

Deciphering the role of LINC00261 and FOXA2 in epithelial-mesenchymal transition and metastasis of pancreatic cancer cells

Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients

C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large b-cell lymphoma patients

MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients

Inflammation, phagocytosis and cancer: another step in the CD47 act

Prediction of response in melanoma therapy by systemic inflammatory response – one size fits not all

Epidermal growth factor receptor inhibitors in adjuvant treatment of lung cancer — the more specific, the better?

Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-magnitude of clinical benefit scale (ESMO-MCBS) version 1.1

Non-smoking-associated lung cancer: a distinct entity in terms of tumor biology, patient characteristics and impact of hereditary cancer predisposition

Related objects

Reset password